House Democrats delivered the final votes needed to send President Joe Biden a slimmed-down version of his tax, climate and drug price agenda, overcoming a year of infighting and giving themselves a cornerstone achievement to campaign on for the November congressional election.

North Carolina community, public health, and environmental justice groups asked a federal court on Friday to let them defend health protections offered by a drinking water advisory for two PFAS that the EPA issued in June.

Pesticide maker Nichino America Inc. lost its bid to block a rival from using an allegedly confusingly similar trademark because it didn’t show it’s likely to cause an irreparable injury, the Third Circuit said Friday.

Chevron USA must pursue its challenge to the EPA’s potential regulation of emissions from its offshore oil platforms near California that are being decommissioned in a different court, the D.C. Circuit ruled Friday.

Becton, Dickinson & Co. must defend a revived investor class action claiming it made misleading statements about defects in its infusion pumps, as an amended complaint adds important details about allegedly untrue statements and omissions, a federal judge in New Jersey said.

One of two children who died after being treated with Novartis AG’s Zolgensma was past the US age limit for receiving the gene therapy for spinal muscular atrophy, suggesting the patient was at higher risk for complications.